Categories: HealthcareNews

electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC

ROCKAWAY, N.J., June 14, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest.

Healthcare Virtual Conference Presented by Maxim:
Date: Wednesday, June 21, 2023
Time: 2:00 PM ET
Event: Company Discussion
Virtual viewers: register to join M-Vest here

For more information regarding the conference and to register to watch the presentation live, please visit the conference page here.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.

For more information, visit www.electrocore.com.

Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com

Staff

Recent Posts

Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China

Regulatory clearance of Bentrio in allergic rhinitis for Mainland ChinaNearly 200 million Chinese estimated to…

2 hours ago

Cosmos Health is Forcing the Market to Reframe the Conversation

CHICAGO, IL / ACCESS Newswire / December 19, 2025 / For a long stretch, Cosmos…

2 hours ago

Remedy’s Nutrition® Launches Mega VMT™ High-Potency Multivitamin to Revolutionize Daily Energy and Nutritional Wellness

KEY LARGO, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Remedy's Nutrition®, a trusted natural dietary…

2 hours ago

Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement

Financing included participation by healthcare-dedicated investors alongside existing shareholdersTORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) --…

2 hours ago